These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1781651)

  • 1. Current problems in radiotherapy, chemotherapy and staging of nasopharyngeal carcinoma (NPC).
    Tsao SY; Chua ET
    Ann Acad Med Singap; 1991 Sep; 20(5):649-55. PubMed ID: 1781651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients.
    Teo PM; Kwan WH; Yu P; Lee WY; Leung SF; Choi P
    Clin Oncol (R Coll Radiol); 1996; 8(3):160-6. PubMed ID: 8814370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
    Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
    Chua DT; Wei WI; Sham JS; Cheng AC; Au G
    Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of nasopharyngeal carcinoma.
    Kraiphibul P; Atichartakarn V
    J Med Assoc Thai; 1992 Aug; 75(8):435-44. PubMed ID: 1300360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concurrent chemoradiotherapy followed by adjuvant chemotherapy for stage III-IVa nasopharyngeal carcinoma].
    Hu QY; Liu P; Wang L; Fu ZF
    Ai Zheng; 2007 Apr; 26(4):394-7. PubMed ID: 17430659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Pan JJ; Ng WT; Zong JF; Chan LL; O'Sullivan B; Lin SJ; Sze HC; Chen YB; Choi HC; Guo QJ; Kan WK; Xiao YP; Wei X; Le QT; Glastonbury CM; Colevas AD; Weber RS; Shah JP; Lee AW
    Cancer; 2016 Feb; 122(4):546-58. PubMed ID: 26588425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma.
    Jian JJ; Cheng SH; Prosnitz LR; Tsai SY; Tsai MJ; Huang AT
    Cancer; 1998 Jan; 82(2):261-7. PubMed ID: 9445180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].
    Lin SJ; Pan JJ; Wu JX; Han L; Pan CZ
    Ai Zheng; 2007 Feb; 26(2):208-11. PubMed ID: 17298755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
    Hwang JM; Fu KK; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1099-111. PubMed ID: 9719121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia.
    Lu H; Peng L; Yuan X; Hao Y; Lu Z; Chen J; Cheng J; Deng S; Gu J; Pang Q; Qin J
    Cancer Treat Rev; 2009 Jun; 35(4):345-53. PubMed ID: 19211192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative study of long-term effects between induction chemotherapy and concurrent chemotherapy on patients with local advanced nasopharyngeal carcinoma].
    Wang HB; Chen Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):361-365. PubMed ID: 29871262
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic factors and outcome for nasopharyngeal carcinoma.
    Farias TP; Dias FL; Lima RA; Kligerman J; de Sá GM; Barbosa MM; Gonçalves FB
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):794-9. PubMed ID: 12874084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
    Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
    Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials.
    Cheng SH; Yen KL; Jian JJ; Tsai SY; Chu NM; Leu SY; Chan KY; Tan TD; Cheng JC; Hsieh CY; Huang AT
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):717-26. PubMed ID: 11395240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Weekly paclitaxel with concurrent intensity-modulated radiotherapy for nasopharyngeal carcinoma: outcomes of a tolerance trial].
    Chen CY; Lu TX; Zhao C; Lu LX; Han F; Sun Y
    Ai Zheng; 2007 Apr; 26(4):398-402. PubMed ID: 17430660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy.
    Chao HL; Liu SC; Tsao CC; Lin KT; Lee SP; Lo CH; Huang WY; Liu MY; Jen YM; Lin CS
    J Radiat Res; 2017 Sep; 58(5):654-660. PubMed ID: 28992206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.